Insider Transactions in Q3 2025 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Benjamin Halladay Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11
-0.0%
|
$11
$1.12 P/Share
|
|
Jul 17
2025
|
Benjamin Looker General Counsel |
SELL
Open market or private sale
|
Direct |
1,304
-0.33%
|
$1,304
$1.13 P/Share
|